Helping NET Cancer patients get a timely diagnosis,
the best care and ultimately a cure
If you don’t suspect it you can’t detect it
84% of NET patients
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
The Pheo Para Alliance released two video animations explaining the basics of pheochromocytoma and paraganglioma. Watch and share to help raise awareness about these rare genetic neuroendocrine tumors. What is Pheo? What is Para?
The Carcinoid Cancer Foundation’s newest video is on lung neuroendocrine tumors and DIPNECH, featuring NET expert Dr. Robert Ramirez, oncology nurse navigator Pamela Ryan, and NET patient Paige McMurray. What are the symptoms? How are lung NET patients diagnosed,...
The Neuroendocrine Tumor Research Foundation (NETRF) announced $2.62 million in neuroendocrine tumor (NET) grants to advance research aimed at finding new and innovative treatments for this uncommon cancer. NETRF made the awards to nine investigators dedicated to...